下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Hotline:400-820-3792Inhibitors•ScreeningLibraries•Proteinswww.MedChemENSD2/H3K36me2modulator-1Cat.No.:HY-179427分⼦式:C₄₁H₅₉ClN₂O₅分⼦量:695.37作⽤靶点:HistoneMethyltransferase;Apoptosis;ReactiveOxygenSpecies(ROS)作⽤通路:Epigenetics;Apoptosis;Immunology/Inflammation;MetabolicEnzyme/Protease;NF-κB储存⽅式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY⽣物活性NSD2/H3K36me2modulator-1⼀种⼝服有效的NSD2/H3K36me2调节剂。NSD2/H3K36me2modulator-1与NSD2的SAM⼝袋竞争性结合,有效抑制NSD2表达并抑制H3K36me2甲化。NSD2/H3K36me2modulator-1还能逆转上⽪-间质转化(EMT),抑制细胞迁移,并诱导G0/G1期阻滞和细胞凋亡(apoptosis)。NSD2/H3K36me2modulator-1可降低线粒体膜电位(MMP)并导致活性氧(ROS)⽣成。NSD2/H3K36me2modulator-1可⽤于研究靶向NSD2的表观遗传抗癌策略在肝细胞癌(HCC)中的应⽤[1]。IC50&TargetNSD2体外研究NSD2/H3K36me2modulator-1(Compound5b)(24h)displaysIC50<5μMagainstallfivecancercelllines(IC50valuesof4.67,2.12,2.64,4.56,4.99μMinA549,HepG-2,PC-3,HCT-116,MCF-7cellsrespectively),confirmingitsexceptionalbroad-spectrumantitumoractivity[1].NSD2/H3K36me2modulator-1exhibitsahightumorselectivityforHepG-2cellsoverHaCaTcells(IC50=19.2μM)(selectivityindex(SI)=9.06)[1].NSD2/H3K36me2modulator-1(2μM,24h,37-62℃)effectivelybindstoNSD2withinHepG-2cells[1].NSD2/H3K36me2modulator-1(2,4μM,24h)inhibitsNSD2andselectivelydownregulatesitsmediatedH3K36me2inHepG-2cells[1].NSD2/H3K36me2modulator-1(2,4μM,24h)reversesEMTatthemolecularlevel,likelythroughNSD2inhibitionandsubsequentTWIST1downregulation,leadingtoalteredexpressionofEpithelial-mesenchymaltransition(EMT)masterregulators[1].NSD2/H3K36me2modulator-1(2,4μM,18,36h)significantlyinhibitsmigrationandproliferationofHepG-2cells[1].NSD2/H3K36me2modulator-1(2,4μM,24h)exertsmultipleregulatoryeffectsonHepG-2cells,includingeffectivelyinducingapoptosis,triggeringconcentration-dependentG0/G1phasearrest,reducing1/3MasterofBioactiveMolecules—您⾝边的抑制剂⼤师www.MedChemEmitochondrialmembranepotential(MMP)dose-dependently,andefficientlypromotingthegenerationofROS[1].WesternBlotAnalysis[1]CellLine:HepG-2cellsConcentration:2,4μMIncubationTime:24hResult:SuppressedNSD2expressioninadose-dependentmanner,withnotablystronginhibitionat4μM.ExhibitedhighselectiveinhibitionofH3K36me2.BoundeffectivelytoNSD2withincells.ApoptosisAnalysis[1]CellLine:HepG-2cellsConcentration:2,4μMIncubationTime:24hResult:SignificantlyincreasedthetotalapoptosisrateinHepG-2cellswiththeelevationoftheconcentration.Exhibitedslightlysuperiorapoptosis-inducingcapacityattheconcentrationof4μM.WesternBlotAnalysis[1]CellLine:HepG-2cellsConcentration:2,4μMIncubationTime:24hResult:SignificantlysuppressedTWIST1expression.Dose-dependentlydownregulatedN-CadherinandVimentin.UpregulatedE-CadherinandOccludininadose-dependentmanner.CellCycleAnalysis[1]CellLine:HepG-2cellsConcentration:0,2,4μMIncubationTime:24hResult:ElevatedtheproportionofHepG-2cellsinG0/G1phasefrom53.8%to65.7%,withtheconcentrationincreasingfrom0to2μM.2/3MasterofBioactiveMolecules—您⾝边的抑制剂⼤师www.MedChemEIncreasedtheG0/G1subpopulationto79.6%,withtheconcentrationreaching4μM,andexceededthatof5-Fluorouracil(HY-90006)(73.5%).InducedamarkeddecreaseinthelevelsofcellcycleregulatorsCDK2,CDK4,andCDK6,effectivelyblockingcellcycleprogressioninaconcentration-dependentmanner.体内研究NSD2/H3K36me2modulator-1(Compound5b)(20,40mg/kg,dailyp.o.for18consecutivedays)exertsrobustantitumoreffectswitheffectivetumorgrowthinhibitionandanacceptablesafetyprofileinaHepG-2cellxenograftmodel,asevidencedbytheabsenceofsignificantdifferencesinthebodyweight,organindices,andmorphologicalfeatures[1].AnimalModel:AnHepG-2xenograftmodelestablishedinfemaleBALB/cnudemice(6-8weeksold)[1]Dosage:20,40mg/kgAdministration:dailyoralgavage(p.o.)for18consecutivedaysResult:Significantlysuppressedtumorgrowthinadose-dependentmanner.Exhibitedthestrongestantitumoreffectat40mg/kg.REFERENCES[1].LvL,etal.Synthesisofamide-linkedpanaxadiol-indolinedionederivatives:AnovelNSD2/H3K36me2epigeneticmodulatorwithsignificantantitumorefficacy.EurJMedChem.2026Jan15;302(Pt
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 脉络膜肿物护理
- 2027年湖南省衡阳市高三下学期第六次检测高考物理试卷(含答案解析)
- 鞍山市2026-2027学年高三压轴卷高考物理试卷(含答案解析)
- 十五五全球化布局:智能床垫控制系统进军中东高端零售
- 掘金智能厨房监控系统万亿蓝海:竞争壁垒与细分赛道突围
- 十五五智能养生壶ESG:全生命周期碳足迹管理与绿色认证
- 浙江浙东北2026-2027学年上学期高二11月期中联考化学试卷
- STEM理念引导下的初中化学项目式学习设计与实施路径探索
- 中药类-药事管理与法规
- 2026年电子黑板行业竞争格局与市场份额分析报告
- (一模)温州市2027届高三第一次适应性考试英语试卷(含答案解析)
- 2026年社区工作者公开招聘考试试题(含详细答案解析)
- 陕西环保集团招聘笔试题库
- 2026年华东理工大学辅导员招聘笔试试题(附答案)
- 世界卫生组织《老年整合照护手册:初级保健中以人为本的评估和路径指南》(第二版)解读
- 2026中国土地二级市场规范化发展路径报告
- 对外投资合作国别(地区)指南 2025 利比里亚
- LY/T 3426-2025直接为林业生产经营服务工程设施用地规范
- 中国马克思主义与当代2024版教材课后思考题答案
- 建筑工地安全奖惩制度
- T-CAWAORG 034-2025 老年主动健康课程设置规范
评论
0/150
提交评论